Rosemary Turner
Known title: DirectorCIK: 0001863747
Associated companies
Transaction History
| MUSA | ▼ Sell | Open Market | 966 | $552K | 8/20/2026 | View on chart |
| MUSA | ▲ Buy | Option Exercise | 617 | $0 | 8/17/2026 | View on chart |
| MUSA | ▲ Buy | Option Exercise | 449 | $0 | 8/17/2026 | View on chart |
| MUSA | ▲ Buy | Option Exercise | 349 | $0 | 2/13/2026 | View on chart |
| MUSA | ▼ Sell | Open Market | 397 | $197K | 2/13/2025 | View on chart |
| MUSA | ▼ Sell | Open Market | 400 | $198K | 2/13/2025 | View on chart |
| MUSA | ▲ Buy | Option Exercise | 797 | $0 | 2/10/2025 | View on chart |
| MUSA | ▼ Sell | Open Market | 205 | $82K | 5/6/2024 | View on chart |
| MUSA | ▲ Buy | Option Exercise | 203 | $0 | 2/9/2024 | View on chart |
| MUSA | ▲ Buy | Option Exercise | 2 | $0 | 2/9/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Zacks analysis reframes Murphy USA risk profile
A recent Zacks article examines how Murphy USA's focus on earnings growth and asset efficiency may be changing how investors view its risk. This analysis highlights operational metrics rather than just price movements. The stock currently trades near its support level, with an average analyst target of $617.80.
Zacks analysis reframes Murphy USA risk profile. A recent Zacks article examines how Murphy USA's focus on earnings growth and asset efficiency may be changing how investors view its risk. This analysis highlights operational metrics rather than just price movements. The stock currently trades near its support level, with an average analyst target of $617.80.